PROCTER & GAMBLE HEALTH | AMI ORGANICS | PROCTER & GAMBLE HEALTH/ AMI ORGANICS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 100.2 | 34.5% | View Chart |
P/BV | x | 10.6 | 7.5 | 140.1% | View Chart |
Dividend Yield | % | 2.0 | 0.2 | 813.2% |
PROCTER & GAMBLE HEALTH AMI ORGANICS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
AMI ORGANICS Mar-23 |
PROCTER & GAMBLE HEALTH/ AMI ORGANICS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,182 | 453.8% | |
Low | Rs | 3,883 | 826 | 470.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 169.2 | 437.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 22.9 | 604.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 26.2 | 591.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 3.00 | 3,166.7% | |
Avg Dividend yield | % | 2.1 | 0.3 | 687.7% | |
Book value per share (Unadj.) | Rs | 447.6 | 163.0 | 274.6% | |
Shares outstanding (eoy) | m | 16.60 | 36.44 | 45.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 5.9 | 105.2% | |
Avg P/E ratio | x | 33.5 | 43.9 | 76.1% | |
P/CF ratio (eoy) | x | 29.8 | 38.3 | 77.9% | |
Price / Book Value ratio | x | 10.3 | 6.2 | 167.7% | |
Dividend payout | % | 68.7 | 13.1 | 523.6% | |
Avg Mkt Cap | Rs m | 76,761 | 36,590 | 209.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 488 | 422.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 6,167 | 199.4% | |
Other income | Rs m | 184 | 43 | 425.7% | |
Total revenues | Rs m | 12,480 | 6,211 | 201.0% | |
Gross profit | Rs m | 3,247 | 1,226 | 264.8% | |
Depreciation | Rs m | 281 | 123 | 227.7% | |
Interest | Rs m | 8 | 24 | 31.9% | |
Profit before tax | Rs m | 3,142 | 1,122 | 280.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 289 | 293.4% | |
Profit after tax | Rs m | 2,295 | 833 | 275.5% | |
Gross profit margin | % | 26.4 | 19.9 | 132.8% | |
Effective tax rate | % | 27.0 | 25.7 | 104.7% | |
Net profit margin | % | 18.7 | 13.5 | 138.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 4,701 | 249.2% | |
Current liabilities | Rs m | 6,791 | 1,628 | 417.0% | |
Net working cap to sales | % | 40.0 | 49.8 | 80.4% | |
Current ratio | x | 1.7 | 2.9 | 59.8% | |
Inventory Days | Days | 263 | 5 | 5,473.1% | |
Debtors Days | Days | 343 | 1,363 | 25.2% | |
Net fixed assets | Rs m | 10,617 | 2,969 | 357.6% | |
Share capital | Rs m | 166 | 364 | 45.6% | |
"Free" reserves | Rs m | 7,265 | 5,575 | 130.3% | |
Net worth | Rs m | 7,431 | 5,940 | 125.1% | |
Long term debt | Rs m | 0 | 6 | 0.0% | |
Total assets | Rs m | 22,330 | 7,669 | 291.2% | |
Interest coverage | x | 409.1 | 47.5 | 861.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 68.5% | |
Return on assets | % | 10.3 | 11.2 | 92.3% | |
Return on equity | % | 30.9 | 14.0 | 220.2% | |
Return on capital | % | 42.4 | 19.3 | 220.0% | |
Exports to sales | % | 0 | 59.1 | 0.0% | |
Imports to sales | % | 13.1 | 30.3 | 43.1% | |
Exports (fob) | Rs m | NA | 3,644 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 1,866 | 86.0% | |
Fx inflow | Rs m | 1,465 | 3,644 | 40.2% | |
Fx outflow | Rs m | 1,605 | 1,866 | 86.0% | |
Net fx | Rs m | -140 | 1,777 | -7.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 655 | 360.1% | |
From Investments | Rs m | -215 | -330 | 65.1% | |
From Financial Activity | Rs m | -985 | -123 | 803.8% | |
Net Cashflow | Rs m | 1,160 | 202 | 573.4% |
Indian Promoters | % | 0.0 | 39.9 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 15.8 | 126.6% | |
FIIs | % | 6.2 | 9.0 | 69.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 60.1 | 80.2% | |
Shareholders | 56,778 | 95,784 | 59.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | AMI ORGANICS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.39% | 0.45% |
1-Month | -1.15% | 8.07% | 2.55% |
1-Year | 0.73% | 17.07% | 56.14% |
3-Year CAGR | -8.76% | 9.09% | 15.22% |
5-Year CAGR | 4.97% | 5.36% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the AMI ORGANICS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of AMI ORGANICS the stake stands at 39.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of AMI ORGANICS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
AMI ORGANICS paid Rs 3.0, and its dividend payout ratio stood at 13.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of AMI ORGANICS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.